BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10439166)

  • 21. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
    Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
    Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
    Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
    Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
    Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
    Shintani SA; Foote RL; Lowe VJ; Brown PD; Garces YI; Kasperbauer JL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):322-9. PubMed ID: 17889447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
    Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
    Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
    Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
    Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
    Périé S; Montravers F; Kerrou K; Angelard B; Tassart M; Talbot JN; Lacau St Guily J
    Ann Otol Rhinol Laryngol; 2002 Sep; 111(9):763-71. PubMed ID: 12296328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
    Vermeersch H; Loose D; Ham H; Otte A; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1689-700. PubMed ID: 14574516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
    Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
    Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
    Fogarty GB; Peters LJ; Stewart J; Scott C; Rischin D; Hicks RJ
    Head Neck; 2003 Feb; 25(2):138-45. PubMed ID: 12509797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in the management of unknown primary head and neck carcinoma.
    Miller FR; Hussey D; Beeram M; Eng T; McGuff HS; Otto RA
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):626-9. PubMed ID: 16027287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
    Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
    Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
    Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
    Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of [18F]-FDG PET-CT in the management of the head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Cammilleri S; Mundler O; Giovanni A; Zanaret M
    Bull Cancer; 2006 Oct; 93(10):1017-25. PubMed ID: 17074660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
    Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
    Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.